Suzhou MedicalSystem Technology Co., Ltd. (SHA:603990)
18.95
-0.39 (-2.02%)
Oct 8, 2026, 11:29 AM CST
SHA:603990 Revenue
Suzhou MedicalSystem Technology had revenue of 61.48M CNY in the quarter ending June 30, 2026, a decrease of -14.46%. This brings the company's revenue in the last twelve months to 289.44M, down -15.61% year-over-year. In the year 2025, Suzhou MedicalSystem Technology had annual revenue of 301.48M, down -35.04%. That makes Suzhou MedicalSystem Technology the world's 28,980th largest company by revenue and 4,897th in China.
Revenue (ttm)
289.44M
Revenue Growth
-15.61%
P/S Ratio
20.16
Revenue / Employee
457.97K
Employees
632
Market Cap
5.72B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 301.48M | -162.59M | -35.04% |
| Dec 31, 2024 | 464.07M | -154.07M | -24.93% |
| Dec 31, 2023 | 618.14M | 312.63M | 102.33% |
| Dec 31, 2022 | 305.51M | -48.34M | -13.66% |
| Dec 31, 2021 | 353.85M | 45.77M | 14.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| WuXi AppTec | 51.52B |
| Shenzhen Mindray Bio-Medical Electronics | 34.29B |
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 31.32B |
| Guangxi LiuYao Group | 21.15B |
| Sichuan Biokin Pharmaceutical | 2.54B |
| Maccura Biotechnology Co.Ltd | 2.13B |
| BMC Medical | 1.38B |
| Chongqing Lummy Pharmaceutical | 748.94M |